A Contemporary Approach to Dysmenorrhea in Adolescents
暂无分享,去创建一个
[1] L. Golub,et al. Exercise and dysmenorrhea in young teenagers: A 3-year study. , 1968, Obstetrics and gynecology.
[2] D. Mishell,et al. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA. , 1977, The Journal of clinical endocrinology and metabolism.
[3] D. M. Potts,et al. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen. , 1977, British medical journal.
[4] V. Lundström,et al. Endogenous levels of prostaglandin F2alpha and its main metabolites in plasma and endometrium of normal and dysmenorrheic women. , 1978, American journal of obstetrics and gynecology.
[5] W. Chan,et al. Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects. , 1978, Prostaglandins.
[6] M. Henzl,et al. Naproxen Sodium in Dysmenorrhea: Its Influence in Allowing Continuation of Work/School Activities , 1978, Obstetrics and gynecology.
[7] S. Emans,et al. New insights into the old problem of chronic pelvic pain. , 1979, Journal of pediatric surgery.
[8] P. Bergsjø. SOCIOECONOMIC IMPLICATIONS OF DYSMENORRHEA , 1979, Acta obstetricia et gynecologica Scandinavica. Supplement.
[9] Dawood My,et al. Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy. , 1980 .
[10] J. Simpson,et al. Heritable aspects of endometriosis. I. Genetic studies. , 1980, American journal of obstetrics and gynecology.
[11] I. Litt,et al. Epidemiology of adolescent dysmenorrhea. , 1981, Pediatrics.
[12] J. Powell,et al. Intrauterine pressure changes during dysmenorrhea therapy. , 1982, American journal of obstetrics and gynecology.
[13] Chatman Dl,et al. Endometriosis in adolescents. , 1982 .
[14] I. Milsom,et al. An epidemiologic study of young women with dysmenorrhea. , 1982, American journal of obstetrics and gynecology.
[15] I. Litt,et al. Current status of the etiology and management of dysmenorrhea in adolescence. , 1982, Pediatrics.
[16] P. Budoff. Zomepirac sodium in the treatment of primary dysmenorrhea syndrome. , 1982, The New England journal of medicine.
[17] S. Roy. A Double-Blind Comparison of a Propionic Acid Derivative (Ibuprofen) and a Fenamate (Mefenamic Acid) in the Treatment of Dysmenorrhea , 1983, Obstetrics and gynecology.
[18] H. Bratt,et al. Clinical Experience with a Triphasic Oral Contraceptive , 1984, Acta obstetricia et gynecologica Scandinavica.
[19] P. Owen. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed. , 1984, American journal of obstetrics and gynecology.
[20] I. Milsom,et al. Effect of various oral contraceptive combinations on dysmenorrhea. , 1984, Gynecologic and obstetric investigation.
[21] S. Levinson. Peptidoleukotriene binding in guinea pig uterine membrane preparations. , 1984, Prostaglandins.
[22] L. Demers,et al. Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea , 1984, British journal of obstetrics and gynaecology.
[23] C. W. Linder,et al. Factors influencing adolescents' responses to regimens of naproxen for dysmenorrhea. , 1985, American journal of diseases of children.
[24] T. Pugsley,et al. Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro. , 1986, Prostaglandins, leukotrienes, and medicine.
[25] M. Forsling,et al. Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive. , 1987, The Journal of endocrinology.
[26] H. Morris,et al. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia. , 1987, The Journal of endocrinology.
[27] D. Mehlisch. Ketoprofen, Ibuprofen, and Placebo in the Treatment of Primary Dysmenorrhea: A Double‐Blind Crossover Comparison , 1988, Journal of clinical pharmacology.
[28] J. Johnson. Level of knowledge among adolescent girls regarding effective treatment for dysmenorrhea. , 1988, Journal of adolescent health care : official publication of the Society for Adolescent Medicine.
[29] Dawood My. Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea. , 1988 .
[30] T. Laudański,et al. Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists. , 1989, Contraception.
[31] Mehlisch Dr. Double-blind crossover comparison of ketoprofen, naproxen, and placebo in patients with primary dysmenorrhea. , 1990 .
[32] G. Creatsas,et al. Prostaglandins: PGF2 alpha, PGE2, 6-keto-PGF1 alpha and TXB2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives. , 1990, European journal of obstetrics, gynecology, and reproductive biology.
[33] A. Simopoulos. Omega-3 fatty acids in health and disease and in growth and development. , 1991, The American journal of clinical nutrition.
[34] J. Rock,et al. The role of laparoscopy in the treatment of endometriosis. , 1991, Fertility and sterility.
[35] S. Nigam,et al. Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. , 1991, Eicosanoids.
[36] M. Forsling,et al. Stimulation of vasopressin release in women with primary dysmenorrhoea and after oral contraceptive treatment—effect on uterine contractility , 1992 .
[37] I. Milsom,et al. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status. , 1992, Contraception.
[38] C. Nathanson,et al. Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic. , 1992, American journal of obstetrics and gynecology.
[39] F. Weber-Diehl,et al. Triphasic combination of ethinyl estradiol and gestodene. Long-term clinical trial. , 1992, Contraception.
[40] M. Forsling,et al. Stimulation of vasopressin release in women with primary dysmenorrhea and after oral contraceptive treatment — Effect on uterine contractility , 1993, British journal of obstetrics and gynaecology.
[41] G. D. Davis,et al. Clinical characteristics of adolescent endometriosis. , 1993, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[42] L. Fedele,et al. Comparative efficacy of diclofenac dispersible 50 mg and ibuprofen 400 mg in patients with primary dysmenorrhea. A randomized, double-blind, within-patient, placebo-controlled study. , 1995, International journal of clinical pharmacology and therapeutics.
[43] C. Kainz,et al. Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. , 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[44] B. Deutch. Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. , 1995, European journal of clinical nutrition.
[45] F. Biro,et al. Depo-Provera in adolescents: effects of early second injection or prior oral contraception. , 1995, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[46] F. Biro,et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. , 1996, American journal of obstetrics and gynecology.
[47] S. Harlow,et al. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women , 1996, British journal of obstetrics and gynaecology.
[48] S. Lurie,et al. Clinical evaluation of a new model of a transcutaneous electrical nerve stimulation device for the management of primary dysmenorrhea. , 1997, Gynecologic and obstetric investigation.
[49] A. Matsuki,et al. Analgesic effect of a herbal medicine for treatment of primary dysmenorrhea--a double-blind study. , 1997, The American journal of Chinese medicine.
[50] T. Kuehl,et al. Extending the Duration of Active Oral Contraceptive Pills to Manage Hormone Withdrawal Symptoms , 1997, Obstetrics and gynecology.
[51] M. Canis,et al. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. , 1997, Fertility and sterility.
[52] P. McGrath,et al. Use of medication by adolescents for the management of menstrual discomfort. , 1997, Archives of pediatrics & adolescent medicine.
[53] S. Emans,et al. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. , 1997, Journal of pediatric and adolescent gynecology.
[54] J. Drazen,et al. Urinary Leukotriene (LT)- E4 in Adolescents with Dysmenorrhea , 1998 .
[55] C. Gordon,et al. "Add-back" therapy for endometriosis in adolescents. , 1998, The Journal of reproductive medicine.
[56] C. Weinberg,et al. Vegetable consumption and risk of chronic disease , 1998 .
[57] P. McGrath,et al. Non-pharmacologic strategies used by adolescents for the management of menstrual discomfort. , 1999, The Clinical journal of pain.
[58] S. Daniels,et al. Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial. , 1999, Obstetrics and gynecology.
[59] M. Laufer,et al. Endometriosis in adolescents. Incidence, diagnosis and treatment. , 1999, The Journal of reproductive medicine.
[60] J. Keogh,et al. Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment. , 1999, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[61] E. Cassese,et al. Influence of menstrual factors and dietary habits on menstrual pain in adolescence age. , 2000, European journal of obstetrics, gynecology, and reproductive biology.
[62] J. Drazen,et al. Urinary leukotriene (LT) E(4) in adolescents with dysmenorrhea: a pilot study. , 2000, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[63] J. Guillebaud. Reducing withdrawal bleeds , 2000, The Lancet.
[64] S. Kelder,et al. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. , 2000, Archives of pediatrics & adolescent medicine.
[65] R. Smith. Continuous topical heat was as effective as ibuprofen for dysmenorrhoea Akin MD,Weingand KW,Hengehold DA,et al. Continuous low›level topical heat in the treatment of dysmenorrhea.Obstet , 2001 .
[66] Roger P. Smith,et al. Continuous Low‐Level Topical Heat in the Treatment of Dysmenorrhea , 2001, Obstetrics and gynecology.
[67] D. Cox,et al. Behavioral treatment parameters with primary dysmenorrhea , 1978, Journal of Behavioral Medicine.